Alzheimer’s Drug Decision Pushed: FDA Slows Down on Donanemab
The Food and Drug Administration has decided to postpone its decision on the approval of Eli Lilly’s candidate Alzheimer’s drug, donanemab. The delay has…
The Food and Drug Administration has decided to postpone its decision on the approval of Eli Lilly’s candidate Alzheimer’s drug, donanemab. The delay has…
Heard of probiotics? They’re those pills — often found in a refrigerated section of the vitamins aisle at your local pharmacy or natural grocer…
Alzheimer’s disease affects millions of people worldwide, and as the world’s population ages, that number is going up. But, the exact cause of Alzheimer’s…
Around 55 million people worldwide suffer from dementia such as Alzheimer’s disease. On Feb. 22, 2024, it was revealed that former talk show host…
Before her diagnosis of mild cognitive impairment and early-stage Alzheimer’s in 2019, Rebecca Chopp was a widely published author, editor, and academic, serving as…
If you or a loved one is going through the diagnostic process for Alzheimer’s, one of the terms you’re likely to hear quite a…
Believe it or not, Pfizer’s drug Viagra was originally designed to treat cardiovascular problems. Early on in clinical trials, men taking the drug became…
This week Being Patient did an extensive series of reports on blood tests for Alzheimer’s, because beyond the headlines, there are a lot of…
Nothing is more exciting than when my favorite basketball team, the Toronto Raptors, announced that they were signing a star player that could help…
Dementia doesn’t just affect the brain of a patient. As clinical psychologist, educator, and author Dasha Kiper explores in her new book, the disease…
Scientists are looking for ways to detect cognitive decline and Alzheimer’s faster, so that they can treat the disease sooner. This research involves discovering…
An Alzheimer’s blood biomarker test can’t actually determine whether or not a person has Alzheimer’s disease — but it can help signal to doctors…
Alzheimer’s blood tests: a new frontier in neurodegenerative diagnostics, getting the world a big step closer to earlier, more accessible Alzheimer’s diagnosis. But it’s…
Biogen renounced ownership of their controversial anti-Alzheimer’s drug Aduhelm after years of dismal sales. The company is also halting an ongoing clinical trial set…
About 14 of every 100 of Black Americans older than 65 have Alzheimer’s disease, compared 10 in 100 white Americans of the same age…